The new timeline is earlier than what Amgen, Horizon Therapeutics and Wall Street analysts were initially expecting after the FTC sued to block the deal.
from Health and Science https://ift.tt/QFRCY3M
https://ift.tt/qbrG6mQ
https://ift.tt/FTMU5qK
No comments:
Post a Comment